Rigel Pharmaceuticals, Inc. (RIGL)

34.00 -1.46 (-4.12%) USD  |  NASDAQ  |  Feb 23, 11:08
More

Rigel Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Nektar Therapeutics Upgrade
Eli Lilly & Co. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade